Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.06 USD | +0.53% | +3.10% | -17.10% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.10% | 6.1B | |
+1.49% | 42.59B | |
+7.58% | 40.65B | |
+48.54% | 40.57B | |
-11.96% | 26.77B | |
+8.13% | 24.81B | |
-24.01% | 18.17B | |
+28.62% | 12.05B | |
-3.01% | 11.7B | |
+7.47% | 11.1B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Ionis Pharmaceuticals Says Bepirovirsen Improves Chronic Hepatitis B Virus Symptoms in GSK's Phase 2b Trial